12 June 2012 - C8 MediSensors Inc, a company involved in developing non-invasive, continuous glucose monitoring for people with diabetes, has announced today that it has raised an incremental USD19m from the sale of Preferred C-1 stock.

The funds will help the company to prepare for its new...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up